TFEB and ovarian cancer: Lysosome can initiate calcium signaling through the TRPML 1/TFEB pathway, which promotes lysosomal cytotoxicity and clearance of accumulated material; lysosomal calcium channel inhibition attenuates lysosomal cytotoxicity and sensitizes drug-resistant ovarian cancer OVCAR8 cells to cisplatin treatment (65).